Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MT-2004 by Shaanxi Micot Technology for Cholestasis: Likelihood of Approval
MT-2004 is under clinical development by Shaanxi Micot Technology and currently in Phase II for Cholestasis. According to GlobalData, Phase...